BIOMAT Database Logo BIOMAT Database Logo

Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis. 1996

J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
Department of Medicine, University of Turku, Finland.

Spontaneous and Borrelia burgdorferi-stimulated proliferation of peripheral blood mononuclear cells (PBMCs) and their interleukin-4 (IL-4), gamma interferon (IFN-gamma), and NO production were measured in 36 patients with second- or third-stage Lyme borreliosis (LB) and 11 control subjects. Spontaneous proliferation of PBMCs was significantly higher (P = 0.0003) in the LB patients than in the control subjects. Spontaneous production of IL-4 was significantly lower in patients than in control subjects (P = 0.0007), but spontaneous production of IFN-gamma was slightly higher in patients. The proliferative response of PBMCs to stimulation with B. burgdorferi was significantly higher (P = 0.01) in patients. The B. burgdorferi-induced production of IFN-gamma (P = 0.002) was also significantly higher in patients. The spontaneous and B. burgdorferi-induced production of NO showed no significant difference between patients and control subjects. These findings indicate that the activation of PBMCs in patients with late LB is enhanced in vivo. Furthermore, the production of IL-4 is effectively suppressed spontaneously, whereas the production of IFN-gamma by PBMCs is slightly increased spontaneously and significantly enhanced during stimulation with B. burgdorferi in vitro. The "spontaneous" or disease-induced alterations in cytokine levels of patients, in this case suppression of a Th2-type cytokine production and activation of a Th1-type cytokine production, may contribute to the pathogenesis of LB.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008193 Lyme Disease An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini (see IXODES) and pacificus ticks in the United States and Ixodes ricinis (see IXODES) in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut. Lyme Borreliosis,B. burgdorferi Infection,Borrelia burgdorferi Infection,Lyme Arthritis,Arthritis, Lyme,B. burgdorferi Infections,Borrelia burgdorferi Infections,Borreliosis, Lyme,Disease, Lyme
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
Interleukin-4 and interferon-gamma production by peripheral blood mononuclear cells from food-allergic patients.
May 1996, Allergy,
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
Salmeterol inhibits interferon-gamma and interleukin-4 production by human peripheral blood mononuclear cells.
March 1996, International journal of immunopharmacology,
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals.
April 1995, Scandinavian journal of immunology,
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome.
September 1984, Clinical and experimental immunology,
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease.
January 1987, Hepatology (Baltimore, Md.),
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
Decreased production of interferon gamma by anti-CD3 monoclonal antibody and interleukin-2-stimulated peripheral blood mononuclear cells in Hodgkin's disease.
November 1995, British journal of haematology,
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
Increased interleukin-1 production by peripheral blood mononuclear cells in patients with multiple sclerosis.
March 1991, Journal of the neurological sciences,
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
In vitro interleukin 4 and interferon-gamma production by mononuclear cells from atopic dermatitis patients.
January 1993, Mediators of inflammation,
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
[Cytogenetic aberrations in peripheral blood mononuclear cells in acute Lyme-borreliosis patients].
January 2013, TSitologiia i genetika,
J Oksi, and J Savolainen, and J Pène, and J Bòusquet, and P Laippala, and M K Viljanen
[A study of gamma-interferon production induced by interleukin 2 in peripheral blood mononuclear cells of patients with hepatocellular carcinoma].
April 1987, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Copied contents to your clipboard!